A Phase 1 interventional study of Gonadotrophin releasing hormone agonist(GnRHa) in GnRHa;LPS, sponsored by Northwest Women's and Children's Hospital, Xi'an, Shaanxi. Status unknown. Open to female participants aged 18 Years to 37 Years. Per ClinicalTrials.gov, last updated 2016-09-21.
Sponsored by Northwest Women's and Children's Hospital, Xi'an, Shaanxi · Phase 1, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The study was designed to investigate the effect of luteal-phase administration of gonadotrophin releasing hormone agonist(GnRHa) on pregnancy outcomes in in-vitro fertilization-embryo transfer.
Northwest Women's and Children's Hospital, Xi'an, Shaanxi is the lead sponsor of 4 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Intervention: additional GnRHa for routine LPS GnRHa group receive three injections of GnRHa(Decapeptyl) ,0.1 mg s.c. on the day of ET, and D3 and D6 after ET in addition to routine LPS.
Drug: Gonadotrophin releasing hormone agonist(GnRHa)
Control group receive only the routine LPS.
GnRHa group receive three injections of GnRHa(Decapeptyl) ,0.1 mg s.c. on the day of ET, and D3 and D6 after ET in addition to routine LPS.
pregnancy rate
Time frame: up to 12 months
No study locations are listed for this record.
The record gives a start of Sep 2016 and a primary completion of Sep 2017. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Sep 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Northwest Women's and Children's Hospital, Xi'an, Shaanxi